Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 dosing regimen study of human lymphoblastoid interferon in hepatitis C with compensated cirrhosis
jRCT2080220087Phase 3
- Sponsor
- Sumitomo Pharma
- Start
- Sep 2005
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label trial of interferon alfa in hepatitis C virus infection and Cirrhosis (2 arms), sponsored by Sumitomo Pharma.
02
Drugs
interferon alfa
03
Conditions
hepatitis C virus infectionCirrhosis
Beyond the preview
Go deeper on jRCT2080220087.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220087.